UK markets close in 14 minutes

Kiromic BioPharma, Inc. (KRBP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.75000.0000 (0.00%)
As of 10:26AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
9,625
9,625
13,920
11,368
5,053
Selling general and administrative
10,314
10,314
17,194
13,938
14,144
Total operating expenses
19,939
19,939
31,114
25,306
19,197
Operating income or loss
-19,939
-19,939
-31,114
-25,306
-19,197
Interest expense
1,852
1,852
166.5
12.2
3.3
Total other income/expenses net
842.2
842.2
-3,450
-270.8
-
Income before tax
-20,949
-20,949
-34,731
-25,589
-19,200
Income from continuing operations
-20,949
-20,949
-34,731
-25,589
-19,200
Net income
-20,949
-20,949
-34,731
-25,589
-19,200
Net income available to common shareholders
-23,499
-23,499
-35,076
-25,811
-19,913
Basic EPS
-19.51
-12.59
-64.42
-67.81
-132.60
Diluted EPS
-19.51
-12.59
-64.42
-67.81
-132.60
Basic average shares
932.02
1,098
544.475
380.607
150.195
Diluted average shares
932.02
1,098
544.475
380.607
150.195